Dosage and administration
USE AS DIRECTED BY YOUR PHYSICIAN.
USE AS DIRECTED BY YOUR PHYSICIAN.
Each Multivitamin with 0.5 mg Fluoride Tablet Contains:
| Vitamin A (as Acetate) | 2500 IU |
| Vitamin C | 60 mg |
| Vitamin D | 400 IU |
| Vitamin E | 15 IU |
| Thiamine | 1.05 mg |
| Riboflavin | 1.2 mg |
| Niacin | 13.5 mg |
| Vitamin B6 | 1.05 mg |
| Folate (as Folic Acid) | 0.3 mg |
| Vitamin B12 | 4.5 mcg |
| Fluoride (as Sodium Fluoride)* | 0.5 mg |
* Each Multivitamin with 0.5 mg Fluoride Tablet contains 0.5 mg Fluoride from 1.1 mg Sodium Fluoride (NaF).
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IF OVERDOSAGE IS SUSPECTED, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY 1-800-222-1222. TABLET SHOULD BE CHEWED. THIS PRODUCT, AS WITH ALL CHEWABLE TABLETS, IS NOT RECOMMENDED FOR CHILDREN UNDER AGE 4 DUE TO RISK OF CHOKING.
DO NOT USE IF FOIL SEAL UNDER CAP IS BROKEN OR MISSING
USE AS DIRECTED BY YOUR PHYSICIAN.
Off-white to pale yellow, speckled, fruit flavor, round-shaped chewable tablet debossed "SCI" on one side and "5" on the other.
Do not use this product if you are allergic to any of the ingredients. Take this product at least 2 hours before or after taking any products containing calcium (including milk, yogurt, other dairy products) or aluminum/magnesium hydroxide (e.g., certain antacids/laxatives). Prolonged daily ingestion of excessive fluoride may result in varying degrees of dental fluorosis. Account for all daily sources of fluoride intake.
Xylitol, microcrystalline cellulose, mannitol, talc, magnesium stearate, sucralose, natural fruit flavor, citric acid.
Store in a cool, dry place at room temperature 20° - 25°C (68° - 77°F) away from heat and sunlight. Store in original container.
This medical food product is formulated to be administered orally, under the ongoing supervision of a physician and is intended for the dietary management of dental caries for which a distinctive nutritional requirement of fluoride, based on recognized scientific principles, has been established by medical evaluation.
The numeric identifier on this product's labeling is an assigned product code for use with pharmacy-level, health-insurance and state level reimbursement programs and is not intended to denote registration with the FDA.
Manufactured by: Sancilio & Co., Inc.
Riviera Beach, FL 33404 USA
rev. 11/18/11
Sancilio &
Company, Inc.
Developing Good Science into Great Medicine™
44946-1024-1
Multivitamin
with Fluoride
Chewable Tablets
NO DYES, ARTIFICIAL FLAVORS OR SUGAR
SACCHARIN AND GLUTEN FREE
CONTAINS XYLITOL
0.5
mg
Dispensed only under the order
of a physician or licensed medical
practitioner†
Dietary
Supplement
100 tablets

| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NIACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44946-1024-1 | Multivitamin with fluoride | 100 in 1 BOTTLE, PLASTIC | TABLET, CHEWABLE | 100 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44946-1024 | MULTIVITAMIN WITH FLUORIDE (.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, SODIUM FLUORIDE, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, THIAMINE, VITAMIN A, AND VITAMIN D) TABLET, CHEWABLE [SANCILIO & COMPANY INC] | 5 | 1 package rows | 20180302_113ec4c4-24f8-450a-8e8f-e0f31b41394e.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44946-1024-1 | EA - Each | 44946-1024 | 8c9ea8f8-acd9-4829-9a1f-248f8f11daf2 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Tocopherol Acetate, DL- | ACTIVE INGREDIENT | WR1WPI7EW8 | 2 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 2 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| Niacin | ACTIVE INGREDIENT | 2679MF687A | 2 | |
| Pyridoxine | ACTIVE INGREDIENT | KV2JZ1BI6Z | 2 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 2 | |
| Sodium Fluoride | ACTIVE INGREDIENT | 8ZYQ1474W7 | 2 | |
| Thiamine | ACTIVE INGREDIENT | X66NSO3N35 | 2 | |
| Vitamin A | ACTIVE INGREDIENT | 81G40H8B0T | 2 | |
| Vitamin D | ACTIVE INGREDIENT | 9VU1KI44GP | 2 | |
| .Alpha.-Tocopherol, DL- | ACTIVE MOIETY | 7QWA1RIO01 | 2 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| Fluoride Ion | ACTIVE MOIETY | Q80VPU408O | 2 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| Niacin | ACTIVE MOIETY | 2679MF687A | 2 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 2 | |
| Thiamine Ion | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| Vitamin A | ACTIVE MOIETY | 81G40H8B0T | 2 | |
| Vitamin D | ACTIVE MOIETY | 9VU1KI44GP | 2 | |
| Anhydrous Citric acid | INACTIVE INGREDIENT | XF417D3PSL | 2 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | 2 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 2 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| Xylitol | INACTIVE INGREDIENT | VCQ006KQ1E | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 44946-1024 | 44946-1024-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| .Alpha.-Tocopherol Acetate, DL- | WR1WPI7EW8 | ACTIM |
| Ascorbic Acid | PQ6CK8PD0R | ACTIB |
| Cyanocobalamin | P6YC3EG204 | ACTIB |
| Sodium Fluoride | 8ZYQ1474W7 | ACTIM |
| Folic Acid | 935E97BOY8 | ACTIB |
| Niacin | 2679MF687A | ACTIB |
| Pyridoxine | KV2JZ1BI6Z | ACTIB |
| Riboflavin | TLM2976OFR | ACTIB |
| Thiamine | X66NSO3N35 | ACTIB |
| Vitamin A | 81G40H8B0T | ACTIB |
| Vitamin D | 9VU1KI44GP | ACTIB |
| Xylitol | VCQ006KQ1E | IACT |
| Microcrystalline Cellulose | OP1R32D61U | IACT |
| Mannitol | 3OWL53L36A | IACT |
| Talc | 7SEV7J4R1U | IACT |
| Magnesium stearate | 70097M6I30 | IACT |
| Sucralose | 96K6UQ3ZD4 | IACT |
| Anhydrous Citric acid | XF417D3PSL | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / SUBLINGUAL | 11 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION / INTRAMUSCULAR | 71 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | 115 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | 7 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SPRAY, METERED / NASAL | 2 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 113 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LOTION / TOPICAL | 211 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 35 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / SUBCUTANEOUS | 99 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | 25 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | 15 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET, EXTENDED RELEASE / ORAL | 2752 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | ELIXIR / ORAL | 90 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | TABLET / BUCCAL | 360 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 105 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | GRANULE / ORAL | 1328 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 300 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING / ORAL | 4364 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | SOLUTION / OPHTHALMIC | 4.7 %w/v | ||
| Talc | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL / TOPICAL | 0.08 %w/w | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | 18 mg | ||
| Anhydrous Citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 414 mg | ||
| Talc | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| Talc | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Mannitol | MANNITOL | 3OWL53L36A | LOZENGE / ORAL | 20546 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 27f5bbc6-3f70-4d87-857c-eb72693cee00 | 113ec4c4-24f8-450a-8e8f-e0f31b41394e | 2018-03-01 | Warnings | 113ec4c4-24f8-450a-8e8f-e0f31b41394e |
Adverse event summaries are temporarily unavailable. Other product information remains available.